Q-omics provides the consensus-scored MIR3671 profile across patient tissues and cancer cell-line models. MIR3671 expression is associated with patient survival in 25 of 34 cancer types, with the highest sampling consensus in UCEC. Among the 18 cancer types available for tumor–normal comparison, MIR3671 is differentially expressed in 10, with the highest sampling consensus in KICH. Additionally, MIR3671 RNA expression shows 17,417 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight UCEC, KICH, and UVM as cancer lineages where MIR3671 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR3671 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR3671 survival associations across molecular data types. MIR3671 RNA expression shows survival associations in the most cancer types (25). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR3671 RNA expression–survival associations across cancer types. High MIR3671 expression shows unfavorable associations in UCEC and UVM, but favorable associations in BRCA, SKCM, PAAD and LUAD. The UCEC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .001). Together, the overview and detailed table identify UCEC as the clearest survival context for MIR3671 RNA expression.
This table summarizes MIR3671 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 10. The strongest signals are observed in KICH for RNA.
This table ranks reproducible tumor–normal expression differences for MIR3671. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR3671 shows lower tumor expression in KICH, KIRP, LUSC, UCEC, BRCA and THCA. The KICH box plot shows higher MIR3671 RNA expression in normal versus tumor tissue (log2 FC = −1.377, t-test p < 0.001).
This table shows molecular features associated with MIR3671 in patient tissues and cancer cell lines. In patient samples, MIR3671 shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
